deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT04893798

A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and Abdomen

A PHASE 1, RANDOMIZED, OPEN-LABEL, SINGLE-DOSE, PARALLEL-GROUP STUDY TO COMPARE THE PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY OF MEDROXYPROGESTERONE ACETATE IN HEALTHY FEMALE PARTICIPANTS FOLLOWING SUBCUTANEOUS INJECTION OF SAYANA PRESS IN THE UPPER ARM RELATIVE TO ANTERIOR THIGH AND ABDOMEN

Sponsor: Pfizer

Conditions Healthy
Interventions Sayana Press
Updated 19 times since 2021 Last updated: Aug 13, 2025 Started: Sep 16, 2021 Primary completion: Jul 24, 2025 Completion: Jul 24, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently completed. Pfizer leads this study, which shows 19 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Jun 2022 · 7 months · monthly snapshot~Jun 2022 – ~Nov 2022 · 5 months · monthly snapshot~Nov 2022 – ~Mar 2023 · 4 months · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~Jul 2023 · 3 months · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Oct 2023 · 2 months · monthly snapshot~Oct 2023 – ~Feb 2024 · 4 months · monthly snapshot~Feb 2024 – ~May 2024 · 3 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Feb 2025 · 3 months · monthly snapshot~Feb 2025 – ~Jun 2025 · 4 months · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  2. Jul 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE1

  3. Jun 2025 — Jul 2025 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  4. Feb 2025 — Jun 2025 [monthly]

    Recruiting PHASE1

  5. Nov 2024 — Feb 2025 [monthly]

    Recruiting PHASE1

▶ Show 14 earlier versions

  1. Sep 2024 — Nov 2024 [monthly]

    Recruiting PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  3. May 2024 — Jul 2024 [monthly]

    Recruiting PHASE1

  4. Feb 2024 — May 2024 [monthly]

    Recruiting PHASE1

  5. Oct 2023 — Feb 2024 [monthly]

    Recruiting PHASE1

  6. Aug 2023 — Oct 2023 [monthly]

    Recruiting PHASE1

  7. Jul 2023 — Aug 2023 [monthly]

    Recruiting PHASE1

  8. Apr 2023 — Jul 2023 [monthly]

    Recruiting PHASE1

  9. Mar 2023 — Apr 2023 [monthly]

    Recruiting PHASE1

  10. Nov 2022 — Mar 2023 [monthly]

    Recruiting PHASE1

  11. Jun 2022 — Nov 2022 [monthly]

    Recruiting PHASE1

  12. Nov 2021 — Jun 2022 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  13. Sep 2021 — Nov 2021 [monthly]

    Not Yet Recruiting PHASE1

  14. Jun 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations